Skip to main content
Veterinary Medicines

Aftovaxpur DOE (49) O1 BFS + A24 Cruzeiro + Asia1 Shamir

Authorised
  • Foot-and-mouth disease virus, serotype O, strain O1 BFS, Inactivated
  • Foot-and-mouth disease virus, serotype A, strain A24 Cruzeiro, Inactivated
  • Foot-and-mouth disease virus, serotype Asia 1, strain Shamir, Inactivated

Auðkenning lyfsins

Heiti lyfs:
Aftovaxpur DOE (49) O1 BFS + A24 Cruzeiro + Asia1 Shamir
Virkt efni:
Dýrategundir:
  • Nautgripir
  • Sauðkind
  • Svín
Íkomuleið:
  • Til notkunar í vöðva
  • Til notkunar undir húð

Upplýsingar um lyfið

Virkt efni / Styrkur:
  • Aðeins í boði í English
    Presentation_strength:≥ 6 PD50 Reference:Hse Index:0
  • Aðeins í boði í English
    Presentation_strength:≥ 6 PD50 Index:11
  • Aðeins í boði í English
    Presentation_strength:≥ 6 PD50 Index:12
Lyfjaform:
  • Stungulyf, fleyti
Withdrawal period by route of administration:
  • Intramuscular use
    • Nautgripir
      • Á ekki við
        0
        dagar
    • Sauðkind
      • Á ekki við
        0
        dagar
    • Svín
      • Á ekki við
        0
        dagar
  • Subcutaneous use
    • Nautgripir
      • Á ekki við
        0
        dagar
    • Sauðkind
      • Á ekki við
        0
        dagar
    • Svín
      • Á ekki við
        0
        dagar
ATC flokkun (dýralyf):
  • QI02AA04
Staða markaðsleyfis:
  • Gilt
Authorised in:
  • Austurríki
  • Belgía
  • Bretland (Norður-Írland)
  • Búlgaría
  • Danmörk
  • Eistland
  • Finnland
  • Frakkland
  • Grikkland
  • Holland
  • Króatía
  • Kýpur
  • Lettland
  • Liechtenstein
  • Litáen
  • Lúxemborg
  • Malta
  • Noregur
  • Portúgal
  • Pólland
  • Rúmenía
  • Slóvakía
  • Slóvenía
  • Spánn
  • Svíþjóð
  • Tékkland
  • Ungverjaland
  • Írland
  • Ísland
  • Ítalía
  • Þýskaland
Áletrun:

Viðbótarupplýsingar

Entitlement type:
  • Markaðsleyfi
Markaðsleyfishafi:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Framleiðandi sem ber ábyrgð á lokasamþykkt:
  • Boehringer Ingelheim Animal Health France
Ábyrgt yfirvald:
  • European Commission
Markaðsleyfisnúmer:
Þessar upplýsingar eru ekki tiltækar fyrir þessa vöru.
Dagsetning leyfisbreytingar:

Skjöl

Combined File of all Documents

íslenzkan (PDF)
Birt á: 19/03/2024
Download
Bulgarian (PDF)
Birt á: 19/03/2024
Croatian (PDF)
Birt á: 19/03/2024
Czech (PDF)
Birt á: 19/03/2024
Danish (PDF)
Birt á: 19/03/2024
Dutch (PDF)
Birt á: 19/03/2024
English (PDF)
Birt á: 19/03/2024
Estonian (PDF)
Birt á: 19/03/2024
Finnish (PDF)
Birt á: 19/03/2024
French (PDF)
Birt á: 19/03/2024
German (PDF)
Birt á: 19/03/2024
Greek (PDF)
Birt á: 19/03/2024
Hungarian (PDF)
Birt á: 19/03/2024
Italian (PDF)
Birt á: 19/03/2024
Latvian (PDF)
Birt á: 19/03/2024
Lithuanian (PDF)
Birt á: 19/03/2024
Maltese (PDF)
Birt á: 19/03/2024
Norwegian (PDF)
Birt á: 19/03/2024
Polish (PDF)
Birt á: 19/03/2024
Portuguese (PDF)
Birt á: 19/03/2024
Romanian (PDF)
Birt á: 19/03/2024
Slovak (PDF)
Birt á: 19/03/2024
Slovenian (PDF)
Birt á: 19/03/2024
Spanish (PDF)
Birt á: 19/03/2024
Swedish (PDF)
Birt á: 19/03/2024

ema-puar-aftovaxpur-v-2292-var-ii-0009-en.pdf

English (PDF)
Birt á: 6/02/2023
Download

ema-puar-aftovaxpur-v-2292-par-en.pdf

English (PDF)
Birt á: 6/02/2023
Download

ema-puar-aftovaxpur-v-2292-var-ii-0001-en.pdf

English (PDF)
Birt á: 6/02/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."